Skip to main content

Convalescence clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Convalescent Plasma to Stem Coronavirus (CSSC-001)

    open to eligible people ages 18 years and up

    Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma versus control (SARS-CoV-2 non-immune plasma) in subjects exposed to Coronavirus disease (COVID-19) at day 28.

    at UC Davis UC Irvine UCLA UCSD

Last updated: